GlassScriptPhysician profile
Lacy Parker
NPI 1720375363
$2,574.00
in general payments reported to CMS, 2019-2025
25 companies · $424 in 2025
The $424 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $168 · 2021: $425 · 2022: $509 · 2023: $450 · 2024: $328 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $739.19 | 2019-2023 | |
| Organon LLC | $454.91 | 2021-2025 | Nexplanon, Nuvaring |
| Mayne Pharma Commercial LLC | $291.06 | 2022-2025 | |
| Hologic Sales and Service, LLC | $155.67 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $125.27 | 2021-2025 | |
| Amgen INC. | $117.89 | 2019-2024 | Evenity, Prolia |
| Astellas Pharma US INC | $82.87 | 2020-2025 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $63.82 | 2024-2025 | |
| Therapeuticsmd, INC. | $59.51 | 2019-2021 | |
| Coopersurgical, INC. | $54.26 | 2020-2025 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $54.08 | 2021-2022 | |
| Avion Pharmaceuticals | $53.36 | 2019-2021 | |
| Sage Therapeutics, LLC | $43.37 | 2021-2024 | |
| Roche Diagnostics Corporation | $38.85 | 2019 | |
| Sumitomo Pharma America, INC. | $33.57 | 2025 | Myfembree |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $29.55 | 2021 | |
| Vertical Pharmaceuticals, LLC | $27.68 | 2019-2020 | |
| Conmed Corporation | $27.08 | 2025 | Airseal |
| Merck Sharp & Dohme LLC | $24.34 | 2020 | |
| Dexcom, INC. | $23.72 | 2025 | Dexcom G6 Transmitter |
| Baudax Bio INC. | $16.39 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.90 | 2022 | |
| Duchesnay USA Incorporated | $15.84 | 2019 | |
| Allergan, INC. | $12.99 | 2019 | |
| Davol INC. | $12.83 | 2023 | Channel Drain |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacy Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.